Search Results
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
33.3%). Participants treated with oral semaglutide 25 mg were more likely to achieve ≥15% body weight reduction, compared with those who received placebo. Within the semaglutide group, more people who achieved ≥15% body weight reduction saw larger improvements than those with <15% weight reduction in systolic
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
33.3%). Participants treated with oral semaglutide 25 mg were more likely to achieve ≥15% body weight reduction, compared with those who received placebo. Within the semaglutide group, more people who achieved ≥15% body weight reduction saw larger improvements than those with <15% weight reduction in systolic
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:00 ET A LANDMARK NATIONAL CONFERENCE TO EXPOSE THE HIDDEN EPIDEMIC OF FAMILY COURT VIOLENCE
The conference is intended to lay the foundation for a full Congressional Hearing on Family Court abuses. It builds on the momentum of a growing body of state legislatures holding official hearings on the human toll of the Family Courts and calls for a Uniform Family Court Code.
More news about: Institute of Forensic Science
Nov 05, 2025, 08:00 ET AeroPress Celebrates 20 Years with Launch of First-Ever Manual Coffee Grinder and New Premium Black and White Editions
laser-etched branding, combining elevated aesthetics with the brand's patented 3-in-1 brew technology. Delivering the smoothness of a pour-over, the full body of a French press and the richness of espresso in under two minutes, the Premium edition, now available in three colors, offers the perfect gift for
More news about: AeroPress
Nov 05, 2025, 06:00 ET Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
obstructive HCM (oHCM), where the thickened muscle creates a blockage in the heart's main pumping chamber, making it harder for blood to flow out to the body with each heartbeat. Approximately one-third of patients have non-obstructive HCM (nHCM), where there is no obstruction, but the muscle is still thickened,
More news about: Braveheart Bio
Nov 05, 2025, 03:22 ET Mindful Escape Awaits at The Westin Resort & Spa Ubud, Bali
sense of serenity. Inside the room, delicate notes of white tea paired with the Sleep Well lavender balm invite a deep exhale, allowing the mind and body to settle. Thoughtfully designed details—calming colour palettes, natural textures, and soft lighting—come together to create a personal sanctuary where
More news about: The Westin Resort & Spa Ubud, Bali
Nov 05, 2025, 02:42 ET Mindful Escape Awaits at The Westin Resort & Spa Ubud, Bali
sense of serenity. Inside the room, delicate notes of white tea paired with the Sleep Well lavender balm invite a deep exhale, allowing the mind and body to settle. Thoughtfully designed details—calming colour palettes, natural textures, and soft lighting—come together to create a personal sanctuary where
More news about: The Westin Resort & Spa Ubud, Bali
Nov 05, 2025, 01:38 ET CTEK Powers The Unveil Of The Ruffian35: A Modern Masterpiece Born From The Soul Of A 1935 Plymouth
The Ruffian Plymouth GT-1 is a hot rod like no other. Its carbon fiber fenders sit gracefully atop an original all-steel 1930s Plymouth body, preserving every mark of history—from scratches and dents to patches of patina—now sealed under deep clear coat. The result is an authentic time capsule
More news about: CTEK
Nov 05, 2025, 00:30 ET Tinnitus UK Rates Lenire as Most Effective Treatment Option
/PRNewswire/ -- Tinnitus UK, Europe's leading tinnitus advocacy body, has announced that Lenire by
More news about: Neuromod Devices
Nov 04, 2025, 20:06 ET FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
a new chemical entity (NCE) and third-generation novel prodrug that modulates glutamate, the most abundant excitatory neurotransmitter in the human body. The primary mode of action of troriluzole is reducing synaptic levels of glutamate. Troriluzole increases glutamate uptake from the synapse, by augmenting
More news about: Biohaven Ltd.
Nov 04, 2025, 19:10 ET Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025
Efficacy: Body weight changes from baseline were 6.3% reduction (multiple ascending dose (MAD) 2, n=8, 40 mg), 4.3% reduction (MAD 1, n=7, 20 mg), and 0.2% increase (placebo, n=6). No plateau was observed at Day 29. Body weight change from baseline was 4.8% reduction
More news about: Ascletis Pharma Inc.
Nov 04, 2025, 16:02 ET Axon to Acquire Carbyne, Uniting Cloud Infrastructure and AI to Redefine the 911 Experience
and governments to companies, frontline workers, and communities. Our trusted network connects TASER energy devices, cameras and sensors including body-worn, fixed and in-car cameras, drones and robotics, digital evidence and records management, real-time operations, immersive training, productivity tools,
More news about: Axon
Nov 04, 2025, 16:01 ET MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025
energy expenditure in DIO mice. Comparative analyses focused on energy expenditure relative to tirzepatide and on body composition relative to pemvidutide, along with assessments of body weight and lipid metabolism in both treatment groups. Compared to tirzepatide, DA-1726 produced
More news about: MetaVia Inc.
Nov 04, 2025, 16:01 ET Axon reports Q3 2025 revenue of $711 million, up 31% year over year
Orleans Parish Communications District about Carbyne Axon Body Workforce Mini In September, we introduced Axon Body Workforce (ABW) Mini, our second dedicated enterprise product, which we expect to begin early deployments
More news about: Axon
Nov 04, 2025, 15:00 ET Honey Play Box Offers Stress Relief This Holiday Season With Innovative App-Controlled Wellness Device
NOCTURA: Realistic Comfort: Crafted from lifelike, body-safe silicone for a natural, soothing feel. App Connectivity: Real-time remote control for interactive
More news about: Honey Play Box
Nov 04, 2025, 14:47 ET ADLM releases new guidance on coagulation testing to improve care for patients on blood thinners
Academy of Diagnostics & Laboratory Medicine has now created a guidance document on this topic that organizes and simplifies key points from a large body of previously published research and medical reports. Major recommendations from the document include the following:
More news about: Association for Diagnostics & Laboratory Medicine (ADLM)
Nov 04, 2025, 14:00 ET CIR-0602K Demonstrates Synergistic Metabolic Benefit with Tirzepatide: New Data Presented at ObesityWeek 2025
mitochondrial metabolism, reducing insulin resistance in cells and driving metabolic benefits in organs throughout the body. This markedly improves glycemic control in diabetes, body composition in obesity, liver function and fibrosis in metabolic dysfunction-associated steatohepatitis (MASH), and outcomes
More news about: Cirius Therapeutics
Nov 04, 2025, 13:52 ET UK Edge Data Center Market to Hit USD 3.12 Billion by 2035, Growing at 17.22% CAGR - DC Market Insights
countries, noting that obtaining planning permission and grid access in the UK can require five to seven years. The UK AI trade body released a report in January 2025 titled "Overcoming the Energy Hurdle to Win in AI," analyzing the significant additional energy consumption required
More news about: DC Market Insights
Nov 04, 2025, 13:15 ET InventHelp Inventor Develops Wearable Wellness & Habit Reform Device (TLS-949)
Nov. 4, 2025 /PRNewswire/ -- "I wanted to create a wearable wellness and habit reform device designed to focus on body and mental health," said an inventor, from Sarasota, Fla., "so I invented the HALO. My design allows you to track health data, monitor fitness and sleep,
More news about: InventHelp
Nov 04, 2025, 12:04 ET Currax Announces ObesityWeek® Data Showing that CONTRAVE® Helps Curb Cravings and Offers Marked Effectiveness in Certain Populations with Obesity
better weight-related outcomes. Among those who completed treatment and were ≥90% adherent to medication at week 56, nearly half lost ≥10% of their body weight, 34% reached BMI <30 kg/m2 and 24% reached a healthy waist circumference. Dr. Caroline Apovian,
More news about: Currax Pharmaceuticals LLC
Nov 04, 2025, 12:00 ET RO TO PRESENT EIGHT RESEARCH ABSTRACTS AT OBESITYWEEK 2025
events among patients treated with branded tirzepatide through Ro's platform. At 12 months, patients achieved an average weight loss of 19.5% of their body weight, and nearly all achieved meaningful weight loss (losing ≥5% of baseline weight). The results are comparable to outcomes observed in clinical
More news about: Ro
Nov 04, 2025, 11:00 ET VASA Fitness Announces $30 Million Investment to Elevate Member Experience Across 64 Locations
including additional stair mills and treadmills, as well as an expansion of lower-body strength equipment such as pendulum squats, vertical leg presses, and Booty Builder machines, reflecting strong consumer demand for lower-body training. These upgrades are designed to meet the evolving needs of members,
More news about: VASA Fitness
Nov 04, 2025, 10:31 ET Honoring Warriors This Veterans Day
help their transition to civilian life," WWP CEO Lt. Gen. (Ret.) Walt Piatt said. "Wounded Warrior Project works to bring each veteran home, in mind, body, and spirit, to a life of purpose." Losing an Identity WWP found
More news about: Wounded Warrior Project
Nov 04, 2025, 10:30 ET Bariatric Beds Market to Reach $583.8 million, Globally, by 2034 at 5.3% CAGR: Allied Market Research
comfort, and effective treatment for this patient's population. Bariatric beds are specifically engineered to support higher weight capacities and wider body dimensions, reducing the risk of injuries to both patients and caregivers. In addition, the rise in bariatric surgeries such as gastric bypass and sleeve
More news about: Allied Market Research
Nov 04, 2025, 10:00 ET Doubling Down for Canada's Pups: The Canadian Kennel Club and the Nation's Top Pet Insurer, Trupanion, Reaffirms Alliance to Give Puppies the Best Start
About the Canadian Kennel Club The Canadian Kennel Club (CKC) is the primary registry body for purebred dogs in Canada and currently recognizes 187 breeds. As a non-profit organization, the CKC is dedicated to advancing the interests of purebred
More news about: Trupanion